US Sunshine Act

Forbes : How Can Big Pharma Restore A Reputation?

According to this Washington Post longread by Peter Whoriskey, the bald truth about industry-funded clinical trials for new drugs is not pretty. As Whoriskey tells it, no one’s quite sure how to give industry-funded trial results a makeover so that the good studies don’t suffer the reputation of the bad ones. Lire l’article de Forbes

Read More »